133.27
+1.25
+(0.95%)
At close: April 17 at 6:52:31 PM GMT+1
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 5 | 5 | 5 | 5 |
Avg. Estimate | 2.71B | 2.79B | 11.27B | 12.24B |
Low Estimate | 2.66B | 2.73B | 11.13B | 11.64B |
High Estimate | 2.75B | 2.84B | 11.53B | 12.88B |
Year Ago Sales | 2.94B | 2.54B | 11.34B | 11.27B |
Sales Growth (year/est) | -7.81% | 9.51% | -0.58% | 8.56% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
0HYE.L | -- | -- | -- | -- |
S&P 500 | 6.92% | 5.09% | 8.78% | 14.15% |
Upgrades & Downgrades
Maintains | Keefe, Bruyette & Woods: Outperform to Outperform | 4/9/2025 |
Maintains | Keefe, Bruyette & Woods: Outperform to Outperform | 2/13/2025 |
Maintains | Roth MKM: Buy to Buy | 2/12/2025 |
Maintains | Piper Sandler: Neutral to Neutral | 10/29/2024 |
Maintains | Keefe, Bruyette & Woods: Outperform to Outperform | 10/29/2024 |
Maintains | B of A Securities: Buy to Buy | 10/10/2024 |